|
|||||
|
|
Use of recombinant HCV antigen in the serodiagnosis of hepatitis C virus infection: Significant improvement in HCV antibody detection as compared with the first generation HCV C100-3 ELISA and the synthetic peptide EIA tests |
|
| Authors: | D. Y. CHIEN Q-L. CHOO A. TABRIZI C. KUO J. McFARLAND K. BERGER C. LEE J. R. SHUSTER T. NGUYEN D. L. MOYER M. TONG S. FURUTA M. OMATA C. T. FONG G. TEGTMEIER H. ALTER E. SCHIFF L. JEFFERS M. HOUGHTON G. KUO |
| Affiliation: | *Chiron Corporation, Emeryville, CA;†Huntington Memorial Hospital, Liver Center, Pasadena, CA;††Community Blood Center of Greater Kansas City, MO;‡‡Department of Transfusion Medicine Clinical Center, National Institutes of Health, Bethesda, MD;§§Center for Liver Disease, Division of Hepatology, University of Miami School of Medicine, Miami, FL;**American Red Cross, Rockville, MD, USA;†Shinshu University School of Medicine, 3-1-1, Asaki Matsumoto, Nyano-keu;§Chiba University School of Medicine, Chiba, Japan |
| Abstract: | |
| Keywords: | Key words C25 protein hepatitis C virus recombinant HCV antigen. |